间质性肺疾病中的夜间低氧血症:一项系统综述
临床显著夜间低氧血症最常见定义为睡眠时间≥10%伴血氧饱和度<90%,汇总患病率为37%。夜间低氧血症与DLCO受损及提示肺动脉高压的超声心动图特征相关,并可能是预后因素。
要点
- 临床显著夜间低氧血症定义为睡眠时间≥10%伴SpO2<90%,ILD中汇总患病率37%。
- 夜间低氧血症与DLCO受损及提示肺动脉高压的超声心动图特征一致相关。
- 两项小样本短期干预显示1-3 L/min supplemental oxygen可纠正夜间低氧血症并改善心率及抗氧化指标。
核心结论
- 夜间低氧血症在ILD患者中常见,与DLCO受损及提示肺动脉高压的标志物相关,并可能是预后因素。
- 需建立夜间低氧血症的共识定义并评估夜间补充氧疗的长期效果。
研究设计与样本
- 在可能的情况下进行荟萃分析及亚组分析。
主要发现
- 临床显著夜间低氧血症最常见定义为睡眠时间≥10%伴血氧饱和度<90%,汇总患病率为37%。
- 按ILD亚型和合并阻塞性睡眠呼吸暂停状态分组的汇总患病率无显著差异。
- 研究异质性妨碍了关联和预后的荟萃分析。
- DLCO和提示肺动脉高压的超声心动图特征与夜间低氧血症一致相关。
- 多数研究的多变量分析显示夜间低氧血症与生存率显著相关。
关键数值与推荐
- 临床显著夜间低氧血症定义:睡眠时间≥10%伴血氧饱和度<90%,汇总患病率37%。
- 两项小样本短期干预研究显示补充氧1-3 L/min可纠正夜间低氧血症,实验室观察期间心率控制改善,治疗1个月后血清抗氧化水平升高。
临床怎么用
- 对ILD患者应关注夜间低氧血症,尤其DLCO受损或超声心动图提示肺动脉高压者。
- 补充氧1-3 L/min可纠正夜间低氧血症并可能改善心率及抗氧化指标,但长期效果待评估。
局限性
- 研究异质性妨碍了关联和预后的荟萃分析。
- 夜间低氧血症与ILD亚型及严重程度的关联不一致。
- 干预研究样本量小且为短期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with interstitial lung disease (ILD) are at risk of developing nocturnal hypoxaemia due to ventilatory restriction and impaired gas exchange that worsen with supine posture and reduced ventilatory drive during sleep. This systematic review synthesised literature on the diagnostic evaluation, epidemiology, associations, management and prognosis of nocturnal hypoxaemia in ILD. METHODS: Ovid MEDLINE, Embase and CENTRAL databases were searched for eligible studies. Meta-analyses with subgroup analyses were conducted, where possible. RESULTS: Fifty-three studies were included (total participant number=2590). The most common definition for clinically significant nocturnal hypoxaemia was ≥10% of total sleep time with oxyhaemoglobin saturation <90%, with pooled prevalence of 37%. There were no significant differences in pooled prevalence according to ILD subtype and comorbid obstructive sleep apnoea status. Study heterogeneity precluded meta-analysis of associations and prognosis. Diffusing capacity for carbon monoxide (DLCO) and echocardiographic features for pulmonary hypertension were consistently associated with nocturnal hypoxaemia. There were inconsistent associations between nocturnal hypoxaemia with ILD subtype and severity. Multivariable analyses in most studies demonstrated significant associations of nocturnal hypoxaemia with survival. Two small short-term intervention studies demonstrated that supplemental oxygen of 1-3 L/min corrected nocturnal hypoxaemia, with improved heart rate control during in-laboratory observation and increased serum antioxidant levels after 1 month of therapy. CONCLUSION: Nocturnal hypoxaemia is common, associated with DLCO impairment and markers suggestive of pulmonary hypertension, and a potential prognostic factor in patients in ILD. There is a need to establish a consensus definition of nocturnal hypoxaemia and evaluate long-term effects of nocturnal supplemental oxygen in ILD.
引用
- Khor YH, Ng Y, Sweeney D, et al. Nocturnal hypoxaemia in interstitial lung disease: a systematic review. Thorax. 2021. PMID: 33927018. doi:10.1136/thoraxjnl-2020-216749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。